We highlight evidence for sexual dimorphism in preclinical and clinical studies investigating the cause and treatment of cancer cachexia.
INTRODUCTION
Cancer-induced cachexia is a complex and progressive wasting condition that is clinically identified by more than 5% bodyweight loss over a 6-month period [ ]. Therefore, we highlight the rationale for investigating sex differences in the development and treatment of cancerinduced muscle wasting. The review emphasizes several well described sex differences in skeletal muscle physiology and function that have clear implications for advancing the understanding of mechanistic drivers of cancer-induced muscle wasting.
CANCER-INDUCED DISRUPTION TO SKELETAL MUSCLE AND SEXUAL DIMORPHISM

Skeletal muscle fiber type and function
Skeletal muscle has been classically characterized by contractile, fatigue, and metabolic properties [22] [23] [24] . This characterization has led to broad fiber type classifications: glycolytic [II(B,X)], oxidative-glycolytic (IIA), and oxidative (I) [23] . Type II glycolytic myofibers have been reported to be more sensitive to cancer-induced muscle wasting than type I myofibers in cancer patients and mouse models [25] . Cancer-induced muscle wasting is also associated with reduced myofiber oxidative metabolism [ 
KEY POINTS
Skeletal muscle has sexual dimorphic properties that have strong potential to influence the mechanistic underpinnings of cancer-induced muscle wasting.
Cancer-induced systemic inflammation can disrupt the IGF-1/Akt/mTORC1 axis and mitochondria function, which have been widely investigated as regulators of cachexia progression and also have strong potential to be differentially regulated in males and females.
The role of hypogonadism in cancer-induced muscle wasting has significant implications for the identification of sexually dimorphic mechanisms of cachexia regulation.
Resistance exercise has strong therapeutic potential for the maintenance and recovery of muscle mass in both male and female cancer patients.
Sex is an important biological variable that needs to be accounted for in the design of human and preclinical cancer cachexia research. 
POTENTIAL THERAPEUTIC INTERVENTIONS
Resistance exercise
Resistance exercise is a nonpharmacological intervention that can modulate muscle fiber composition, protein turnover, oxidative phosphorylation, and hormones, and it has been extensively reviewed ]. This understanding extends to well described sexual dimorphism in aspects of skeletal muscle function and metabolism. Sex differences also extend to essential muscle properties involving muscle regeneration after injury [3 && ]. Despite a strong premise for sexual dimorphism in mechanisms that drive muscle wasting, we have a very limited understanding of how sex can influence cancer cachexia progression. We highlight several mechanistic regulators of skeletal muscle wasting that have potential for sexually dimorphic responses that could impact the prevention and treatment of cancer cachexia in both males and females (Fig. 2) .
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